270 related articles for article (PubMed ID: 7044021)
21. Oral contraceptives and the risk of breast cancer.
Grant EC
N Engl J Med; 2002 Oct; 347(18):1448-9; author reply 1448-9. PubMed ID: 12418035
[No Abstract] [Full Text] [Related]
22. [Contraceptive pills today].
Larsson-Cohn U
Lakartidningen; 1967 Jun; 64(25):2566-72. PubMed ID: 5597573
[No Abstract] [Full Text] [Related]
23. Oral contraceptives and neoplasia. WHO Scientific Group.
World Health Organ Tech Rep Ser; 1992; 817():1-46. PubMed ID: 1539455
[No Abstract] [Full Text] [Related]
24. [Use of oral contraceptives and risk of cancer].
Bjørge T; Engeland A
Tidsskr Nor Laegeforen; 2002 Aug; 122(18):1788-90. PubMed ID: 12362690
[No Abstract] [Full Text] [Related]
25. Oral contraception: safety issues re-examined.
Shulman LP
Int J Fertil Womens Med; 1999; 44(2):78-82. PubMed ID: 10338265
[TBL] [Abstract][Full Text] [Related]
26. The pill, breast and cervical cancer, and the role of progestogens in arterial disease.
Lincoln R
Fam Plann Perspect; 1984; 16(2):55-63. PubMed ID: 6373360
[No Abstract] [Full Text] [Related]
27. Serious adverse effects of oral contraceptives and estrogens.
Med Lett Drugs Ther; 1976 Feb; 18(5):21-2. PubMed ID: 1256357
[No Abstract] [Full Text] [Related]
28. [Family planning. Clinical practice and problems].
Staemmler HJ; Jörger G
Dtsch Med Wochenschr; 1971 May; 96(22):959-64. PubMed ID: 4931172
[No Abstract] [Full Text] [Related]
29. Risks of oral contraceptive use in women over 35.
Stenchever MA
J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
[TBL] [Abstract][Full Text] [Related]
30. [What effects estrogen and progesterone have in the development of breast cancer, thrombosis and the function of the vocal cords].
Pulkkinen M
Duodecim; 1996; 112(4):282-3. PubMed ID: 10590642
[No Abstract] [Full Text] [Related]
31. [Organic changes as affected by oral steroid contraception in female inbred Buffalo rats].
Markuszewski C
Patol Pol; 1981; 32(4):487-503. PubMed ID: 7343892
[No Abstract] [Full Text] [Related]
32. [Conn's adenoma after prolonged treatment with estro-progestins. 2 cases].
Leichtmann GA; Louis J; Houplon M; Houplon R; Duc M
Nouv Presse Med; 1980 Feb; 9(7):460. PubMed ID: 7360656
[TBL] [Abstract][Full Text] [Related]
33. [Hormonal contraception and cardiac infarction].
Husby G
Tidsskr Nor Laegeforen; 1968 Dec; 88(23):2196-8. PubMed ID: 5710340
[No Abstract] [Full Text] [Related]
34. Oral contraception: trends over time.
Yuzpe AA
J Reprod Med; 2002 Nov; 47(11 Suppl):967-73. PubMed ID: 12497670
[TBL] [Abstract][Full Text] [Related]
35. [Clinical experiences with the 2-phase preparation Biogest Spofa for hormonal contraception].
Flach W; Hamann B
Z Arztl Fortbild (Jena); 1977 Jan; 71(1):38-40. PubMed ID: 855375
[No Abstract] [Full Text] [Related]
36. The pill revisited.
Connell EB
Fam Plann Perspect; 1975; 7(2):62-71. PubMed ID: 1092557
[No Abstract] [Full Text] [Related]
37. [Effect of oral contraceptives and epsilon-aminocaproic acid on pregnant female rats and their fetuses. Histopathologic study].
Niznikowska-Marks MJ; Oknińska A; Gawlik Z; Grygalewicz J; Galczak W; Ostojska J
Patol Pol; 1981; 32(1):37-52. PubMed ID: 6171763
[No Abstract] [Full Text] [Related]
38. [Breast cancer and use of antihypertensive drugs and oral contraceptives: results of a case-control study (author's transl)].
Clavel F; Lê M; Laplanche A
Bull Cancer; 1981; 68(5):449-55. PubMed ID: 7332791
[TBL] [Abstract][Full Text] [Related]
39. Minimising risk in contraception.
Tate P
Practitioner; 1997 Oct; 241(1579):571-4, 576, 580. PubMed ID: 9926590
[TBL] [Abstract][Full Text] [Related]
40. Risk of cancer development in relation to oral contraception.
Lech MM; Ostrowska L
Eur J Contracept Reprod Health Care; 2006 Sep; 11(3):162-8. PubMed ID: 17056445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
